# Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)

> **NCT01589952** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegalyted interferon, Entecavir

## Key facts

- **NCT ID:** NCT01589952
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589952, "Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01589952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*